McKesson Corporation and Clayton, Dubilier & Rice (CD&R) announced on October 6, 2026, a definitive agreement to acquire Option Care Health, Inc. The transaction values Option Care Health at approximately $5.8 billion, or $32.05 per share.
Under the terms of the agreement, CD&R will hold a majority ownership interest of approximately 51%, while McKesson will invest approximately $1.4 billion for a minority interest of approximately 49%. Option Care Health will continue to operate as a separate company led by its existing management team. McKesson intends to account for its minority interest using the equity method of accounting.
The deal represents a premium of approximately 37% to Option Care Health’s closing share price on October 5, 2026. The transaction is expected to close in the first half of calendar year 2027, subject to customary closing conditions, including approval by Option Care Health’s stockholders and required regulatory approvals. Upon completion, Option Care Health will become a privately held company.
McKesson stated that the acquisition aligns with its strategy to expand access to innovative therapies and improve care delivery in lower-cost community settings. Option Care Health is the nation’s largest independent provider of home and alternate site infusion services.
